| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| DICE Therapeutics, Inc. | CEO, Director | Common Stock | 0 | $46.50 | 09 Aug 2023 | Direct | |
| DICE Therapeutics, Inc. | CEO, Director | Restricted Stock Unit (RSU) | 0 | 09 Aug 2023 | Direct | ||
| DICE Therapeutics, Inc. | CEO, Director | Stock Option (right to buy) | 0 | 09 Aug 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000120919123045172-judice-kevin-2023-08-09 | DICE Therapeutics, Inc. | 09 Aug 2023 | 8 | $0 | 4 | CEO, Director | 09 Aug 2023, 16:25 |
| /report/000120919123027770-judice-kevin-2023-05-03 | DICE Therapeutics, Inc. | 03 May 2023 | 1 | -$499,977 | 4 | CEO, Director | 05 May 2023, 17:03 |
| /report/000120919123005763-judice-kevin-2023-01-27 | DICE Therapeutics, Inc. | 27 Jan 2023 | 2 | $0 | 4 | CEO, Director | 31 Jan 2023, 16:30 |
| /report/000120919122024831-judice-kevin-2022-04-14 | DICE Therapeutics, Inc. | 14 Apr 2022 | 1 | $0 | 4 | CEO, Director | 19 Apr 2022, 18:52 |
| /report/000120919121056519-judice-kevin-2021-09-14 | DICE Therapeutics, Inc. | 14 Sep 2021 | 6 | $0 | 4 | CEO, Director | 16 Sep 2021, 21:18 |
| /report/000120919121056030-judice-kevin-2021-09-14 | DICE Therapeutics, Inc. | 14 Sep 2021 | 0 | $0 | 3 | CEO, Director | 14 Sep 2021, 19:01 |